Brief: Catalyst Pharmaceuticals Appoints Daniel Curran, MD, To Its Board Of Directors
04/08/2025 13:49
Aug 4 (Reuters) - Catalyst Pharmaceuticals Inc CPRX.O: CATALYST PHARMACEUTICALS APPOINTS DANIEL CURRAN, MD, TO ITS BOARD OF DIRECTORS Source text: ID:nGNXbNzdDL Further company coverage: CPRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xilio Therapeutics
See all newsXilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Xilio Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla